Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(10):724-732; doi:10.1093/jnci/dji129
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (107)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Cardis, E.
Right arrow Articles by Williams, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cardis, E.
Right arrow Articles by Williams, D.
Related Collections
Right arrowCorrespondence about this Article
Right arrowEditorial about this Article
Right arrowRelated Memo to the Media
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

ARTICLE

Risk of Thyroid Cancer After Exposure to 131I in Childhood

Elisabeth Cardis, Ausrele Kesminiene, Victor Ivanov, Irina Malakhova, Yoshisada Shibata, Valeryi Khrouch, Vladimir Drozdovitch, Evaldas Maceika, Irina Zvonova, Oleg Vlassov, André Bouville, Guennadi Goulko, Masaharu Hoshi, Alexander Abrosimov, Jadvyga Anoshko, Larisa Astakhova, Sergey Chekin, Evgenyi Demidchik, Rosaria Galanti, Masahiro Ito, Elena Korobova, Evgenyi Lushnikov, Marat Maksioutov, Vladimir Masyakin, Alexander Nerovnia, Vladimir Parshin, Evgenyi Parshkov, Nikolay Piliptsevich, Aldo Pinchera, Semyon Polyakov, Nina Shabeka, Eero Suonio, Vanessa Tenet, Anatoli Tsyb, Shunichi Yamashita, Dillwyn Williams

Affiliations of authors: International Agency for Research on Cancer, Lyon, France (EC, AK, VD, VT); Medical Radiological Research Center RAMS, Obninsk, the Russian Federation (VI, OV, AA, SC, EL, MM, VP, EP, AT); Belarusian Center for Medical Technologies, Computer Systems, Administration and Management of Health, Minsk, Belarus (IM, SP, NS); Nagasaki University, Nagasaki, Japan (YS, SY); State Research Center—Institute of Biophysics, Moscow, the Russian Federation (VK); Institute of Physics, Vilnius, Lithuania (EM); Research Institute of Radiation Hygiene, St. Petersburg, the Russian Federation (IZ); National Cancer Institute, Bethesda, MD (AB); Clinic and Policlinic for Nuclear Medicine, Bayerische Julius-Maximilians University of Würzburg, Germany (GG); Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan (MH); Institute of Geological Sciences of the National Academy of Sciences of Belarus, Minsk, Belarus (JA); Center of Laser Medicine, Childhood Polyclinic No. 8, Minsk, Belarus (LA); Belarusian State Medical University, Minsk, Belarus (ED); Centre for Tobacco Prevention, Stockholm Centre of Public Health and Clinical Epidemiology Unit, Karolinska University Hospital, Sweden (RG); National Nagasaki Medical Center, Nagasaki, Japan (MI); Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Moscow, the Russian Federation (EK); Republican Research Centre of Radiation Medicine and Human Ecology, Gomel, Belarus (VM); Belarusian State Medical University, Minsk, Belarus (AN, NP); Department of Endocrinology and Metabolism, University of Pisa, Italy (AP); Clinic of Oncology, Turku University Hospital, Turku, Finland (ES); Strangeways Research Laboratory, Cambridge, U.K. (DW)

Correspondence to: E. Cardis, PhD, International Agency for Research on Cancer, Lyon, France (e-mail: cardis{at}iarc.fr).

Background: After the Chernobyl nuclear power plant accident in April 1986, a large increase in the incidence of childhood thyroid cancer was reported in contaminated areas. Most of the radiation exposure to the thyroid was from iodine isotopes, especially 131I. We carried out a population-based case–control study of thyroid cancer in Belarus and the Russian Federation to evaluate the risk of thyroid cancer after exposure to radioactive iodine in childhood and to investigate environmental and host factors that may modify this risk. Methods: We studied 276 case patients with thyroid cancer through 1998 and 1300 matched control subjects, all aged younger than 15 years at the time of the accident. Individual doses were estimated for each subject based on their whereabouts and dietary habits at the time of the accident and in following days, weeks, and years; their likely stable iodine status at the time of the accident was also evaluated. Data were analyzed by conditional logistic regression using several different models. All statistical tests were two-sided. Results: A strong dose–response relationship was observed between radiation dose to the thyroid received in childhood and thyroid cancer risk (P<.001). For a dose of 1 Gy, the estimated odds ratio of thyroid cancer varied from 5.5 (95% confidence interval [CI] = 3.1 to 9.5) to 8.4 (95% CI = 4.1 to 17.3), depending on the risk model. A linear dose–response relationship was observed up to 1.5–2 Gy. The risk of radiation-related thyroid cancer was three times higher in iodine-deficient areas (relative risk [RR]= 3.2, 95% CI = 1.9 to 5.5) than elsewhere. Administration of potassium iodide as a dietary supplement reduced this risk of radiation-related thyroid cancer by a factor of 3 (RR = 0.34, 95% CI = 0.1 to 0.9, for consumption of potassium iodide versus no consumption). Conclusion: Exposure to 131I in childhood is associated with an increased risk of thyroid cancer. Both iodine deficiency and iodine supplementation appear to modify this risk. These results have important public health implications: stable iodine supplementation in iodine-deficient populations may substantially reduce the risk of thyroid cancer related to radioactive iodines in case of exposure to radioactive iodines in childhood that may occur after radiation accidents or during medical diagnostic and therapeutic procedures.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Correspondence about this Article

Re: Risk of Thyroid Cancer After Exposure to 131I in Childhood
Bobby R. Scott
J Natl Cancer Inst 2006 98: 561. [Extract] [Full Text] [PDF]

Re: Risk of Thyroid Cancer After Exposure to 131I in Childhood
Charles M. Grossman and Rudi H. Nussbaum
J Natl Cancer Inst 2006 98: 641. [Extract] [Full Text] [PDF]

Editorial about this Article

Radiation-induced Thyroid Cancer—What's New?
John D. Boice, Jr.
J Natl Cancer Inst 2005 97: 703-705. [Extract] [Full Text] [PDF]

Related Memo to the Media

Press Release: Iodine Deficiency, Supplementation Affect Thyroid Cancer Risk in Children Exposed to Radioactive Iodine
Sarah L. Zielinski
J Natl Cancer Inst 2005 97: 701. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
N. M Akulevich, V. A Saenko, T. I Rogounovitch, V. M Drozd, E. F Lushnikov, V. K Ivanov, N. Mitsutake, R. Kominami, and S. Yamashita
Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma
Endocr. Relat. Cancer, June 1, 2009; 16(2): 491 - 503.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Tubiana, L. E. Feinendegen, C. Yang, and J. M. Kaminski
The Linear No-Threshold Relationship Is Inconsistent with Radiation Biologic and Experimental Data
Radiology, April 1, 2009; 251(1): 13 - 22.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Hatch, A. Brenner, T. Bogdanova, A. Derevyanko, N. Kuptsova, I. Likhtarev, A. Bouville, V. Tereshchenko, L. Kovgan, V. Shpak, et al.
A Screening Study of Thyroid Cancer and Other Thyroid Diseases among Individuals Exposed in Utero to Iodine-131 from Chernobyl Fallout
J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 899 - 906.
[Abstract] [Full Text] [PDF]


Home page
Radiat Prot DosimetryHome page
J. Rosina, E. Kvasnak, D. Suta, T. Kostrhun, and D. Drabova
Czech Republic 20 years after Chernobyl accident
Radiat Prot Dosimetry, July 1, 2008; 130(4): 452 - 458.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Agate, S. Mariotti, R. Elisei, P. Mossa, F. Pacini, E. Molinaro, L. Grasso, L. Masserini, T. Mokhort, T. Vorontsova, et al.
Thyroid Autoantibodies and Thyroid Function in Subjects Exposed to Chernobyl Fallout during Childhood: Evidence for a Transient Radiation-Induced Elevation of Serum Thyroid Antibodies without an Increase in Thyroid Autoimmune Disease
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2729 - 2736.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. B. Zablotska, T. I. Bogdanova, E. Ron, O. V. Epstein, J. Robbins, I. A. Likhtarev, M. Hatch, V. V. Markov, A. C. Bouville, V. A. Olijnyk, et al.
A Cohort Study of Thyroid Cancer and Other Thyroid Diseases after the Chornobyl Accident: Dose-Response Analysis of Thyroid Follicular Adenomas Detected during First Screening in Ukraine (1998-2000)
Am. J. Epidemiol., February 1, 2008; 167(3): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
P. Brindel, F. Doyon, F. Rachedi, J.-L. Boissin, J. Sebbag, L. Shan, V. Chungue, L. Y. K. Sun, F. Bost-Bezeaud, P. Petitdidier, et al.
Menstrual and Reproductive Factors in the Risk of Differentiated Thyroid Carcinoma in Native Women in French Polynesia: A Population-based Case-Control Study
Am. J. Epidemiol., January 15, 2008; 167(2): 219 - 229.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
R. Guignard, T. Truong, Y. Rougier, D. Baron-Dubourdieu, and P. Guenel
Alcohol Drinking, Tobacco Smoking, and Anthropometric Characteristics as Risk Factors for Thyroid Cancer: A Countrywide Case-Control Study in New Caledonia
Am. J. Epidemiol., November 15, 2007; 166(10): 1140 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Radiat Prot DosimetryHome page
V. Drozdovitch, E. Maceika, V. Khrouch, I. Zvonova, O. Vlasov, A. Bouville, and E. Cardis
Uncertainties in individual doses in a case-control study of thyroid cancer after the Chernobyl accident
Radiat Prot Dosimetry, November 1, 2007; 127(1-4): 540 - 543.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
K. Baverstock
The recognition of childhood thyroid cancer as a consequence of the Chernobyl accident: an allegorical tale of our time?
J R Soc Med, September 1, 2007; 100(9): 407 - 409.
[Full Text] [PDF]


Home page
Vet PatholHome page
K. A. B. Knostman, S. M. Jhiang, and C. C. Capen
Genetic Alterations in Thyroid Cancer: The Role of Mouse Models
Vet. Pathol., January 1, 2007; 44(1): 1 - 14.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. D. Tronko, A. V. Brenner, V. A. Olijnyk, J. Robbins, O. V. Epstein, R. J. McConnell, T. I. Bogdanova, D. J. Fink, I. A. Likhtarev, J. H. Lubin, et al.
Autoimmune Thyroiditis and Exposure to Iodine 131 in the Ukrainian Cohort Study of Thyroid Cancer and Other Thyroid Diseases after the Chornobyl Accident: Results from the First Screening Cycle (1998-2000)
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4344 - 4351.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. C. Travis and M. G. Stabin
131I Ablation Treatment in Young Females After the Chernobyl Accident
J. Nucl. Med., October 1, 2006; 47(10): 1723 - 1727.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. O. Hoffman, A. J. Ruttenber, S. Greenland, and R. J. Carroll
Radiation exposure and thyroid cancer.
JAMA, August 2, 2006; 296(5): 513 - 513.
[Full Text] [PDF]


Home page
JAMAHome page
J. D. Boice Jr
Radiation Exposure and Thyroid Cancer--Reply
JAMA, August 2, 2006; 296(5): 514 - 514.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. D. Tronko, G. R. Howe, T. I. Bogdanova, A. C. Bouville, O. V. Epstein, A. B. Brill, I. A. Likhtarev, D. J. Fink, V. V. Markov, E. Greenebaum, et al.
A Cohort Study of Thyroid Cancer and Other Thyroid Diseases After the Chornobyl Accident: Thyroid Cancer in Ukraine Detected During First Screening.
J Natl Cancer Inst, July 5, 2006; 98(13): 897 - 903.
[Abstract] [Full Text] [PDF]


Home page
Radiat Prot DosimetryHome page
V. Drozdovitch, M. Germenchuk, and A. Bouville
Using total beta-activity measurements in milk to derive thyroid doses from Chernobyl fallout
Radiat Prot Dosimetry, July 1, 2006; 118(4): 402 - 411.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. G. Saad, S. Kumar, E. Ron, J. H. Lubin, J. Stanek, K. E. Bove, and Y. E. Nikiforov
Proliferative Activity of Human Thyroid Cells in Various Age Groups and Its Correlation with the Risk of Thyroid Cancer after Radiation Exposure
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2672 - 2677.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. M. Grossman and R. H. Nussbaum
Re: Risk of thyroid cancer after exposure to (131)I in childhood.
J Natl Cancer Inst, May 3, 2006; 98(9): 641 - 641.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
V. Drozdovitch, V. Khrouch, A. Bouville, G. Goulko, I. Zvonova, and E. Cardis
RESPONSE: Re: Risk of Thyroid Cancer After Exposure to 131I in Childhood
J Natl Cancer Inst, May 3, 2006; 98(9): 641 - 642.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B. R. Scott
Re: Risk of thyroid cancer after exposure to (131)I in childhood.
J Natl Cancer Inst, April 19, 2006; 98(8): 561 - 561.
[Full Text] [PDF]


Home page
JAMAHome page
J. D. Boice Jr
Thyroid Disease 60 Years After Hiroshima and 20 Years After Chernobyl
JAMA, March 1, 2006; 295(9): 1060 - 1062.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. D. Boice Jr.
Radiation-induced Thyroid Cancer--What's New?
J Natl Cancer Inst, May 18, 2005; 97(10): 703 - 705.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.